Cristea Alexandra M, Zaharia Dragos C, Dumitrache-Rujinski Stefan, Tintea Alexandra, Bogdan Miron A
Department of Pneumology, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Department of Pneumology, Marius Nasta Institute of Pneumology, Bucharest, ROU.
Cureus. 2023 Jun 26;15(6):e40996. doi: 10.7759/cureus.40996. eCollection 2023 Jun.
The abnormal presence of free air in the thorax, pneumothorax, and pneumomediastinum are complications for critically ill patients suffering from coronavirus disease 2019 (COVID-19). The development of these events may lead to a poor prognosis and make the management of this category of patients more difficult.
We performed an observational retrospective study, including patients with SARS-CoV-2 infection and pneumonia who were hospitalized, to analyze the cases that developed pneumothorax or pneumomediastinum as a complication.
A total of 28 cases (1.51%) from 1844 patients with SARS-CoV-2 pneumonia developed pneumothorax or pneumomediastinum during hospitalization. Of them, 21 (75%) needed intensive care unit admission and ventilation, and 10 (35.71) were cured.
The male gender is more probable to be involved in the development of pneumothorax or pneumomediastinum in patients with SARS-CoV-2 pneumonia. The incidence of these events is low, and conservative treatment could provide a better outcome.
胸部出现游离气体、气胸和纵隔气肿是2019冠状病毒病（COVID-19）重症患者的并发症。这些情况的发生可能导致预后不良，并使这类患者的管理更加困难。
我们进行了一项观察性回顾性研究，纳入住院的严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）感染和肺炎患者，以分析发生气胸或纵隔气肿并发症的病例。
1844例SARS-CoV-2肺炎患者中，共有28例（1.51%）在住院期间发生气胸或纵隔气肿。其中，21例（75%）需要入住重症监护病房并接受通气治疗，10例（35.71%）治愈。
男性更有可能发生SARS-CoV-2肺炎患者气胸或纵隔气肿。这些情况的发生率较低，保守治疗可能会带来更好的结果。
Zotero 插件